Chodorge, Matthieu <br/><br/>
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.  [electronic resource] 

 -  Scientific reports  12 2018 
 - 17545 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/s41598-018-35869-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--pharmacokinetics<br/>CHO Cells<br/>Cricetulus<br/>Diabetes Mellitus, Experimental--blood<br/>Diabetes Mellitus, Type 2--blood<br/>Glucagon-Like Peptide 1<br/>Hep G2 Cells<br/>Humans<br/>Hypoglycemic Agents--pharmacokinetics<br/>Macaca fascicularis<br/>Male<br/>Mice<br/>PCSK9 Inhibitors<br/>Recombinant Fusion Proteins--pharmacokinetics